{"id":"fluoresone","rwe":[{"pmid":"6618859","year":"1983","title":"Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports.","finding":"","journal":"Italian journal of neurological sciences","studyType":"Clinical Study"},{"pmid":"14188414","year":"1964","title":"[COMPARATIVE EFFECTS OF PROCALMADIOL, PHENOBARBITAL AND FLUORESONE ON THE TOXICITY OF THE METHAMPHETAMINE GROUP].","finding":"","journal":"Comptes rendus des seances de la Societe de biologie et de ses filiales","studyType":"Clinical Study"},{"pmid":"14041627","year":"1963","title":"[Results of trials with fluoresone or ANP 215 in character disorders].","finding":"","journal":"Annales medico-psychologiques","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"caducid","offLabel":[],"synonyms":["fluoresone","bripadon","caducid","floretione","fluoreson","p-Fluorophenyl ethyl sulfone"],"timeline":[],"approvals":[],"brandName":"Caducid","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Unfortunately, there is not enough information to provide a plain English explanation of Caducid's mechanism of action.","oneSentence":"Unfortunately, there is not enough information to provide a one-sentence summary of Caducid's mechanism of action.","technicalDetail":"Unfortunately, there is not enough information to provide technical pharmacology detail on Caducid's mechanism of action."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3235","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FLUORESONE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:34:13.086437","biosimilars":[],"competitors":[],"genericName":"fluoresone","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"343BH0S0XR","CHEBI":"CHEBI:134835","INN_ID":"1214","UMLSCUI":"C0619286","ChEMBL_ID":"CHEMBL93309","PUBCHEM_CID":"71814","MESH_SUPPLEMENTAL_RECORD_UI":"C038907"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":3,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1983 Jun","pmid":"6618859","title":"Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports.","journal":"Italian journal of neurological sciences"},{"date":"1964","pmid":"14188414","title":"[COMPARATIVE EFFECTS OF PROCALMADIOL, PHENOBARBITAL AND FLUORESONE ON THE TOXICITY OF THE METHAMPHETAMINE GROUP].","journal":"Comptes rendus des seances de la Societe de biologie et de ses filiales"},{"date":"1963 May","pmid":"14041627","title":"[Results of trials with fluoresone or ANP 215 in character disorders].","journal":"Annales medico-psychologiques"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Caducid, also known as Fluoresone, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not known if it is FDA approved or off-patent. There is limited information available on its approved indications, half-life, bioavailability, and generic manufacturers. Further research is needed to understand the full scope of Caducid's use and characteristics. As a result, key safety considerations and mechanism of action are also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}